Transmedics Group Inc’s recent filing unveils that its Chief Commercial Officer Khayal Tamer I unloaded Company’s shares for reported $0.44 million on Oct 01 ’24. In the deal valued at $148.24 per share,2,958 shares were sold. As a result of this transaction, Khayal Tamer I now holds 20,843 shares worth roughly $2.9 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hassanein Waleed H sold 8,625 shares, generating $1,323,210 in total proceeds. Upon selling the shares at $153.42, the President & CEO now owns 61,643 shares.
Before that, Khayal Tamer I sold 2,960 shares. Transmedics Group Inc shares valued at $472,404 were divested by the Chief Commercial Officer at a price of $159.60 per share. As a result of the transaction, Khayal Tamer I now holds 20,843 shares, worth roughly $2.9 million.
Robert W. Baird initiated its Transmedics Group Inc [TMDX] rating to an Outperform in a research note published on September 24, 2024; the price target was $200. A number of analysts have revised their coverage, including Needham’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. Cantor Fitzgerald began covering TMDX with “an Overweight” recommendation on June 06, 2024. Stephens started covering the stock on June 04, 2024. It rated TMDX as “an Overweight”.
Price Performance Review of TMDX
On Friday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock fall -3.36% to $138.97. Over the last five days, the stock has lost -12.67%. Transmedics Group Inc shares have risen nearly 76.07% since the year began. Nevertheless, the stocks have risen 164.60% over the past one year. While a 52-week high of $177.37 was reached on 08/23/24, a 52-week low of $36.42 was recorded on 03/25/24. SMA at 50 days reached $155.47, while 200 days put it at $118.26.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 135.48, which if violated will result in even more drops to 131.99. On the upside, there is a resistance level at 144.72. A further resistance level may holdings at 150.47. The Relative Strength Index (RSI) on the 14-day chart is 39.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.10%. Stochastics %K at 6.82% indicates the stock is a buying.
How much short interest is there in Transmedics Group Inc?
A steep rise in short interest was recorded in Transmedics Group Inc stocks on 2024-09-13, dropping by -0.57 million shares to a total of 5.5 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.06 million shares. There was a decline of -10.32%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 28, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $95 price target.